Researchers evaluated the patient-specific factors that were associated with a greater risk of advanced disease at the time of melanoma diagnosis.

Immunotherapy among women with 2 types of genital tract melanoma, vulvar and vaginal melanoma, was associated with improved overall survival.

IT’S common knowledge that sun damage can increase your risk of developing skin cancer. But experts have warned that it takes ...

Replimune Group, Inc.'s RP1 + OPDIVO for advanced melanoma gains FDA Priority Review. PDUFA date: July 22, 2025. Read more on ...

Patients with resected melanoma treated with a shorter duration of anti-PD1 therapy did not have worse outcomes than those treated for 12 months.

HonorHealth Research Institute recently treated the first patient in a 50-site international clinical trial that will test a ...

Date & Time: April 28, 2-5 p.m. Summary: Building on findings presented at ASCO 2024, this study demonstrates that DecisionDx-Melanoma can identify early-stage CM ... (7.4% vs. 1.2%, p<0.001 ...

Researchers from the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) have applied AI-driven processes for detecting tertiary ...

After countless appointments, immunotherapy and oral chemo, there are no signs of cancer in Beth’s body. Inspired by his wife ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Registration Link for Presentation and live Q&A to take place, Wednesday, May 7, 2025 at 2:00 pm EST Marlborough, Massachusetts--(Newsfile Corp. - May 1, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: ...